You are now leaving Kedrion Corporate site. Medical information including licensed uses may be different outside of the EU countries.
NO
YES

HIGHLIGHTS

EVENTS

Kedrion Biopharma celebrates World Hemophilia Day 2018

Support for patients with coagulation disorders worldwide is confirmed

read more 

EVENTS

50-Year Anniversary of a Maternal Health Breakthrough

Kedrion Biopharma supports session on Anti-D achievements and challenges at FIGO Congress in Dubai

read more 

CORPORATE

Kedrion Biopharma runner up at the Premio Equita for the bond issued in July 2017

The prize is awarded to the companies that made the best use of the capital markets

read more 
  1. EVENTS - 23-09-2016

    Pharmaceutical digitization: how to improve patient care and engagement

    Kedrion Biopharma Advisor Prof. Albert Farrugia lectures at "The Future of Science" Conference in Venice, Italy

    read more 
  2. PLASMA & BIOTHERAPIES - 16-09-2016

    Humanitarian Factor IX donation to Afghanistan

    Kedrion Biopharma confirms its commitment to broaden access to therapies in developing Countries

    read more 
  3. PLASMA & BIOTHERAPIES - 13-09-2016

    Kedrion and Kamada seek FDA approval of IgG as a post-exposure treatment

    BLA has been submitted on September 1, 2016. Companies planning for decision from FDA in mid-2017

    read more 
  4. EVENTS - 26-07-2016

    SIPPET Study was WHF 2016 World Congress highlight

    A Kedrion, Grifols and LFB supported symposium featured a lecture by Dr. Manuel Carcao

    read more 

Pages

For more information please contact: pressoffice@kedrion.com